Analyst Update: Google Inc, Inogen Inc, and L Brands Inc

Analysts adjusted their ratings on Google Inc (GOOGL), Inogen Inc (INGN), and L Brands Inc (LB)

by Mark Fightmaster

Published on Aug 12, 2015 at 1:36 PM

Analysts are weighing in today on search behemoth Google Inc (NASDAQ:GOOGL), medical tech company Inogen Inc (NASDAQ:INGN), and retail concern L Brands Inc (NYSE:LB). Here's a quick roundup of today's brokerage notes on GOOGL, INGN, and LB.

  • GOOGL was in the news yesterday after announcing the creation of a holding company named Alphabet, and today scored a couple more upgrades and price-target boosts. Morgan Stanley and Baird weighed in on Google Inc this morning, with the former issuing an $820 price target and upgrading the company to "overweight" from "equal weight," and the latter elevating its price target to $780 from $720. Technically, GOOGL has been solid. The stock hit an all-time high of $713.33 on July 22, and has backed off a bit to currently trade at $689.50. That said, performance of GOOGL's ilk is hard to ignore -- and those on Wall Street have taken notice. Optimism reigns in the option pits and brokerage world, but there are still some naysayers. If this group decides to change its tune and become bullish on GOOGL, we could see some further upside momentum.
  • INGN's second-quarter earnings report and upwardly revised sales forecast impressed analysts, and sent the stock 13.8% higher to $48.47. In fact, the shares are just off an all-time high of $50.98. In the wake of this news, three brokerage houses raised their price targets for the medical tech firm: Stifel upped Inogen Inc's price target to $48 from $45, J.P. Morgan Securities elevated its price target to $50 from $40, and Leerink raised its price target to $55 from $45. Much like GOOGL, INGN has been a beast on the charts, boasting a year-to-date lead of nearly 55%, thanks to support from its 10-week moving average. 

  • LB is set to report earnings next week, but the stock is 2.1% lower at $80.74, after BMO cut its price target and rating on the specialty retailer. Specifically, BMO downgraded L Brands Inc to "market perform" from "outperform," and cut its price target to $76 from $103 (a 26% reduction),  attributing the move to heavier-than-expected markdowns on swimwear. The stock is clinging on to support at the round-number $80 level, but with LB's 10-week moving average descending into the region, this support should come under a stern test. This trendline has consistently pushed the shares lower since the middle of April -- when LB was flirting with all-time highs -- and doesn't appear ready to give up its resistive role. A disappointment in the earnings confessional -- perhaps in the same vein as Macy's, Inc. (NYSE:M) -- could prove rather damaging for LB.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Cyberark Software LTD, Capital One Financial Corp., and GoDaddy Inc. and Analyst Downgrades: Cree, Inc., Fossil Group Inc, and Myriad Genetics, Inc.


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.